Health news today spans both high-stakes drug competition and the quieter gaps in everyday care. Novo Nordisk has taken Eli Lilly to federal court, accusing its rival of misleading advertising in the fierce battle over blockbuster GLP-1 treatments, arguing Lilly’s promotions for...
Health news today spans both high-stakes drug competition and the quieter gaps in everyday care. Novo Nordisk has taken Eli Lilly to federal court, accusing its rival of misleading advertising in the fierce battle over blockbuster GLP-1 treatments, arguing Lilly’s promotions for Zepbound and Mounjaro rely on selective, outdated comparisons that overstate their edge over Wegovy and Ozempic. At the consumer end of health tech, Garmin is pushing into the screen-free wearable market with its new Cirqa smart band, betting that distraction-free tracking without a subscription will appeal to users weary of recurring fees. And in a reminder that innovation does not erase basic shortcomings in care, Melinda French Gates says it took three doctors to diagnose her perimenopause, underscoring persistent blind spots in women’s health even for patients with excellent access to medicine.
Top Health stories
- Novo Nordisk sues Eli Lilly over alleged misleading GLP-1 drug advertising (17 sources)
- Garmin Launches Screen-Free Cirqa Smart Band Without Subscription (9 sources)
- RFK Jr. says cyclospora outbreak is under control after FDA recall reversal (6 sources)
- Three teenagers sentenced over murder of Kayden Moy at Irvine Beach (5 sources)
- Neighbour who stabbed woman to death sentenced; victim’s family speaks in court (5 sources)
- Indonesia sentences Lie Siu Luan to seven years for baby trafficking (5 sources)
- Sri Lanka deploys Air Force drones to combat dengue outbreak (5 sources)
- Three teenagers jailed for murder of 16-year-old in Scottish beach knife attack (5 sources)
Tara Tagwell
Author at IfHighLow
